ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB.

April A N Rose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.